Blood Cancer: Clinical Trials

45 trials for Blood Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 16 recruiting, 5 unknown, 3 withdrawn. 13 Not applicable, 12 Phase 2, 9 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable13Completed 4, Recruiting 4, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1
Phase 212Completed 6, Recruiting 4, Active not recruiting 1, Terminated 1
Phase 19Recruiting 4, Completed 3, Terminated 1, Withdrawn 1

Follow Blood Cancer: new trials by email Literature Review of Blood Cancer trials Research Report on Blood Cancer

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
aldesleukin, cyclophosphamide, fludarabine phosphate - Malignancy, Hematologic, Neoplasms, Hematologic
Phase 1RecruitingNational Cancer Institute (NCI)862026-10-292026-10-26
Rutgers University Study of the Genetics of Blood Cancers
Blood Cancers, Blood Cancer
RecruitingRutgers, The State University of New Jersey100002026-09-222026-10-01
A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax
Tagraxofusp, Azacitidine (AZA), Venetoclax - Acute Myeloid Leukaemia (AML), Leukemia
Phase 1 / Phase 2RecruitingJacqueline Garcia, MD312026-02-022026-02-05
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years
practice adapted physical activity, control arm - Child, Only, Blood Cancer
Not applicableRecruitingUniversity Hospital, Clermont-Ferrand302025-11-172025-12-05
Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut
Adult and pediatric patients with hematological diseases treated with allogeneic hematopoietic cell transplantation - Blood Cancer
RecruitingIRCCS Azienda Ospedaliero-Universitaria di Bologna902025-10-152026-01-09
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
Music Therapy/MT, Therapist-Attention Music Education/TAME Control - Blood Cancer, Lymphoma
Not applicableRecruitingMemorial Sloan Kettering Cancer Center602025-06-272026-05-26
Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
genotype-directed dosing with dosing software based on therapeutic drug monitoring - Fungal Infection, Haematological Malignancy
Phase 2RecruitingThe University of Queensland1042025-04-142026-04-16
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Virtual Reality Hypnosis, VRH : Beach, VRH : Forest - Blood Cancer, Multiple Myeloma (MM)
Not applicableNot yet recruitingCiusss de L'Est de l'Île de Montréal602025-02-012025-02-10
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
DIVERSE Review Process - Blood Cancer, Leukemia
Not applicableRecruitingDana-Farber Cancer Institute402024-12-092026-07-16
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue
Time-restricted eating, Nutrition counseling - Neoplasms, Blood Cancer
Phase 2RecruitingUniversity of Maryland, Baltimore962024-11-042026-06-05
Understanding the Implementation of Cued Exercise Using Wearable Devices and a Custom Smartphone Application Following Bone Marrow Transplant.
exercise intervention - Blood Cancer, Bone Marrow Transplant (BMT)
Not applicableActive not recruitingMedical College of Wisconsin152024-10-282025-02-14
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Standard assistance, Enhanced assistance - Bone Cancer, Brain Cancer
Not applicableCompletedWashington University School of Medicine332024-10-042025-08-26
Clinical Evaluation of the Scopio Cell Morphology Technology
Blood cells classification - Blood Cancer
UnknownFondazione Policlinico Universitario Agostino Gemelli IRCCS3002024-09-012024-08-27
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies
Genetic Blood Test - Myeloid Malignancy, Myeloid Malignancies
Not applicableWithdrawnDana-Farber Cancer Institute2024-07-292024-11-22
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention
Mind Over Matter (MOM) - Cancer, Breast Cancer
CompletedInova Health Care Services402024-01-172025-02-27
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
IDP-023, Rituximab, Daratumumab - NHL, Multiple Myeloma
Phase 1 / Phase 2RecruitingIndapta Therapeutics, INC.1282023-10-252025-06-03
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Isatuximab - Blood Cancer, Refractory Immune Cytopenias
Phase 2Active not recruitingMemorial Sloan Kettering Cancer Center122023-07-212026-04-02
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)
Chronic Graft-versus-Host-Disease, Allogeneic Hematopoietic Stem Cell Transplantation
UnknownUniversity of British Columbia3202023-07-012023-12-08
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
KCAT19 T cells - Blood Cancer
Phase 1RecruitingUniversity College, London122023-02-062026-08-11
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy
Palliative Care, Usual Care - Hematologic Malignancy, Blood Cancer
Not applicableRecruitingMassachusetts General Hospital902022-12-302026-04-21

Showing 20 of 45. Sign in to see all of them.

Narrower conditions

Hematologic Neoplasms (45)  ·  Leukemia (17)  ·  Lymphoma (11)  ·  Neoplasms (10)  ·  Multiple Myeloma (7)  ·  Myelodysplastic Syndromes (4)  ·  Brain Neoplasms (3)  ·  Breast Neoplasms (3)  ·  Colorectal Neoplasms (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Neoplasms, Plasma Cell (3)  ·  Bronchiolitis Obliterans Syndrome (2)  ·  Esophageal Neoplasms (2)  ·  Head and Neck Neoplasms (2)

Broader conditions

Hemic and Lymphatic Diseases (45)  ·  Neoplasms by Site (45)  ·  Hematologic Diseases (44)  ·  Neoplasms (35)  ·  Neoplasms by Histologic Type (24)  ·  Immune System Diseases (17)  ·  Immunoproliferative Disorders (15)  ·  Lymphoproliferative Disorders (15)  ·  Lymphatic Diseases (14)  ·  Cardiovascular Diseases (8)  ·  Hemorrhagic Disorders (8)  ·  Vascular Diseases (8)  ·  Blood Protein Disorders (7)  ·  Hemostatic Disorders (7)  ·  Neoplasms, Plasma Cell (7)

Interventions

Antilymphocyte Serum (3)  ·  Cyclophosphamide (3)  ·  Cyclosporine (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Mycophenolic Acid (3)  ·  Filgrastim (2)  ·  Palliative Care (2)  ·  aldesleukin (2)  ·  isatuximab (2)  ·  Acetaminophen (1)  ·  Azacitidine (1)  ·  Bone Marrow Transplantation (1)  ·  Darbepoetin alfa (1)  ·  Data Collection (1)  ·  Diphenhydramine (1)

Sponsors

Stanford University (5)  ·  Brigham and Women's Hospital (2)  ·  Dana-Farber Cancer Institute (2)  ·  Memorial Sloan Kettering Cancer Center (2)  ·  University of British Columbia (2)  ·  Aga Khan University (1)  ·  Alberta Health Services, Calgary (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  AstraZeneca (1)  ·  Blood Cancer United (1)  ·  Case Comprehensive Cancer Center (1)  ·  Ciusss de L'Est de l'Île de Montréal (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  European Society for Blood and Marrow Transplantation (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Countries

United States (30)  ·  Canada (5)  ·  France (3)  ·  Italy (3)  ·  Spain (3)  ·  Australia (2)  ·  Germany (2)  ·  Israel (2)  ·  Poland (2)  ·  United Kingdom (2)  ·  Belarus (1)  ·  Colombia (1)  ·  Georgia (1)  ·  Hungary (1)  ·  Japan (1)

Top investigators

Robert Lowsky (3)  ·  Hermioni Amonoo, MD, MPP, MPH (2)  ·  Andrew C Harris, MD (1)  ·  Andrew Hantel, MD (1)  ·  Brock C Christensen, PhD (1)  ·  Christopher Reilly, MD (1)  ·  David Ogez, Ph.D (1)  ·  Jacqueline Garcia, MD (1)  ·  James N Kochenderfer, M.D. (1)  ·  Jason A Roberts, PhD (1)  ·  Jeremie Zerbit, PharmD (1)

Results publications

PMID 16192477, PMID 19423725, PMID 20528878, PMID 21532851, PMID 21542449, PMID 21622762, PMID 22106690, PMID 22373458, PMID 23244672, PMID 24566820, PMID 24607552, PMID 25909835, PMID 26146806, PMID 28912923, PMID 32519455, PMID 37442349, PMID 37627056, PMID 38363314, PMID 41174725, PMID 41758815, PMID 41783087, PMID 42311030, PMID 4305950

NIH funding

K08CA251654 (1), K08CA273043 (1), UH2AG056933 (1)